
SOPHiA GENETICS S.A.
SOPHiA GENETICS S.A.(SOPH)股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
soph · 股价预测 · 7 位分析师(近3月)· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 7 位华尔街分析师
Buy
7 位分析师
共识
评级分布
12 个月目标价
High
$8.00
Consensus
$7.50
+42.6% upside
Low
$7.00
Median: $7.5 · Last Close: $5.26
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$7.50
42.6% upside
High Target
$8
52.1%
Low Target
$7
33.1%
Current Price
$5.26
as of today
Based on analyst price targets, the SOPH stock price prediction for the next 12 months ranges from $7 to $8. The consensus SOPH price forecast of $7.50 implies 42.6% upside from the current price of $5.26.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $5.33 | ↑ 1.31% |
1-day model range: $5.3–$5.36. Peak: $5.36 (+1.31%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $5 | -1.7% |
| 2028 | $5 | -2.6% |
| 2029 | $5 | -3.1% |
| 2030 | $5 | -3.4% |
| 2031 | — | -3.5% |
基于技术分析的股价预测
14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · SOPH · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-06 | BTIG | Maintains | Buy→Buy |
| 2026-04-15 | BTIG | Maintains | Buy→Buy |
| 2026-01-26 | Guggenheim | Maintains | Buy→Buy |
| 2025-11-10 | BTIG | Maintains | Buy→Buy |
| 2024-08-07 | RBC Capital | Maintains | Outperform→Outperform |
| 2024-03-06 | BTIG | Maintains | Buy→Buy |
| 2024-03-06 | RBC Capital | Maintains | Outperform→Outperform |
| 2024-01-12 | RBC Capital | Maintains | Outperform→Outperform |
| 2023-05-10 | Credit Suisse | Maintains | Neutral→Neutral |
| 2023-05-10 | Morgan Stanley | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on SOPHiA GENETICS S.A. (SOPH) stock. Of the recent 22 rating actions, 0 were upgrades and 0 were downgrades. 7 analysts currently cover SOPH.
分析师推荐趋势
SOPH analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
财务预测:EPS 与营收一致预期
Revenue This Year
$93M
↓ 33.4% YoY
Revenue Next Year
$112M
↑ 20.3% YoY
EPS This Year
$-0.87
EPS Next Year
$-0.66
↓ 24.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast SOPH EPS of $-0.87 for the current fiscal year, based on estimates from 2 analysts. The SOPH revenue forecast is $93M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
SOPH 股价预测由两类独立数据源支撑:来自 7 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。SOPH 的共识目标价为 $7.50(+42.6% 上行空间),分析师共识为 Buy。
SOPH 的短期预测(明日)为 $5.33(+1.31%)。 SOPH 对 2027 年的股价预测均值为 $5。 SOPH 对 2030 年的预测区间为 $5–$5。
SOPHiA GENETICS S.A. 在 NASDAQ 上市,代码 SOPH。SOPH 在 2027 年的整体展望偏积极,在覆盖分析师中约 86% 对应 Buy 共识。
常见问题
SOPH 预测 · 8 个问题根据 7 位华尔街分析师,SOPH 的 12 个月平均目标价为 $7.50,最高 $8.00、最低 $7.00。若有图表,中位目标价可在上方查看。相对当前价 $5.26,隐含约 +42.6% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.